Bill Commons

NJ ACR 55

in committee

Constitutes special committee of Senate and General Assembly entitled "New Jersey Public Employee Health Care Program Costs Investigation Committee."

New Jersey · 222 · lower

Quick answers

Did NJ ACR 55 pass?

Not yet. NJ ACR 55 is in committee as of 2026-01-13 and has not come to a final vote. Latest recorded action (2026-01-13): Introduced, Referred to Assembly Financial Institutions and Insurance Committee

What is NJ ACR 55 about?

NJ ACR 55 is a concurrent resolution in the 222 titled “Constitutes special committee of Senate and General Assembly entitled "New Jersey Public Employee Health Care Program Costs Investigation Committee."”.

Who sponsors NJ ACR 55?

Inganamort, Michael is the primary sponsor of NJ ACR 55, joined by 4 cosponsors.

Introduced
2026-01-13
Latest action
2026-01-13 — Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Bill type
concurrent resolution
Last updated

Sponsors

  • Inganamort, Michaelprimary
  • Myhre, Gregory E.cosponsor
  • Auth, Robertcosponsor
  • Barlas, Alcosponsor
  • Fantasia, Dawncosponsor

Committees

Not provided by source.

Action timeline

  1. 2026-01-13

    Introduced, Referred to Assembly Financial Institutions and Insurance Committee

    introduction,referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:27:43.923511Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=ACR 55. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.